EGFR and embryonal rhabdomyosarcoma: Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that has been shown to be expressed or activated in 32–50% of alveolar and 31–55% of embryonal rhabdomyosarcoma [6, 7].